Back to Search
Start Over
P3.13-09 ALTER-0303 Study: Tumor Mutation Index (TMI) For Clinical Response to Anlotinib in Advanced NSCLC Patients at 3rd Line.
- Source :
- Journal of Thoracic Oncology; Oct2018 Supplement, Vol. 13, pS979-S979, 1p
- Publication Year :
- 2018
Details
- Language :
- English
- ISSN :
- 15560864
- Volume :
- 13
- Database :
- Complementary Index
- Journal :
- Journal of Thoracic Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 132778236
- Full Text :
- https://doi.org/10.1016/j.jtho.2018.08.1849